BlackRock’s Nuvectis Pharma NVCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.8M | Buy |
642,982
+574,498
| +839% | +$4.29M | ﹤0.01% | 3725 |
|
|
2025
Q1 | $669K | Buy |
68,484
+6,142
| +10% | +$60K | ﹤0.01% | 4267 |
|
|
2024
Q4 | $337K | Buy |
62,342
+12,788
| +26% | +$69.2K | ﹤0.01% | 4462 |
|
|
2024
Q3 | $312K | Sell |
49,554
-33,858
| -41% | -$213K | ﹤0.01% | 4379 |
|
|
2024
Q2 | $528K | Sell |
83,412
-289,309
| -78% | -$1.83M | ﹤0.01% | 4281 |
|
|
2024
Q1 | $3.06M | Sell |
372,721
-15,170
| -4% | -$124K | ﹤0.01% | 3800 |
|
|
2023
Q4 | $3.24M | Buy |
387,891
+28,444
| +8% | +$237K | ﹤0.01% | 3788 |
|
|
2023
Q3 | $4.63M | Buy |
359,447
+44,956
| +14% | +$579K | ﹤0.01% | 3628 |
|
|
2023
Q2 | $5.02M | Buy |
314,491
+300,935
| +2,220% | +$4.81M | ﹤0.01% | 3651 |
|
|
2023
Q1 | $178K | Buy |
13,556
+3,395
| +33% | +$44.5K | ﹤0.01% | 4727 |
|
|
2022
Q4 | $76.2K | Sell |
10,161
-3,842
| -27% | -$28.8K | ﹤0.01% | 5038 |
|
|
2022
Q3 | $100K | Buy |
14,003
+6,805
| +95% | +$48.6K | ﹤0.01% | 5084 |
|
|
2022
Q2 | $80K | Sell |
7,198
-674
| -9% | -$7.49K | ﹤0.01% | 5206 |
|
|
2022
Q1 | $59K | Buy |
+7,872
| New | +$59K | ﹤0.01% | 5301 |
|